Literature DB >> 21737484

Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cells.

Biola M Javierre1, Javier Rodriguez-Ubreva, Fatima Al-Shahrour, Marina Corominas, Osvaldo Graña, Laura Ciudad, Xabier Agirre, David G Pisano, Alfonso Valencia, Jose Roman-Gomez, Maria Jose Calasanz, Felipe Prosper, Manel Esteller, Rogelio Gonzalez-Sarmiento, Esteban Ballestar.   

Abstract

Transcription factors are common targets of epigenetic inactivation in human cancer. Promoter hypermethylation and subsequent silencing of transcription factors can lead to further deregulation of their targets. In this study, we explored the potential epigenetic deregulation in cancer of Ikaros family genes, which code for essential transcription factors in cell differentiation and exhibit genetic defects in hematologic neoplasias. Unexpectedly, our analysis revealed that Ikaros undergoes very specific promoter hypermethylation in colorectal cancer, including in all the cell lines studied and around 64% of primary colorectal adenocarcinomas, with increasing proportions in advanced Duke's stages. Ikaros hypermethylation occurred in the context of a novel long-range epigenetic silencing (LRES) region. Reintroduction of Ikaros in colorectal cancer cells, ChIP-chip analysis, and validation in primary samples led us to identify a number of direct targets that are possibly related with colorectal cancer progression. Our results not only provide the first evidence that LRES can have functional specific effects in cancer but also identify several deregulated Ikaros targets that may contribute to progression in colorectal adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737484     DOI: 10.1158/1541-7786.MCR-10-0515

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  25 in total

1.  Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival.

Authors:  David H Murray; Erin L Symonds; Graeme P Young; Susan Byrne; Philippa Rabbitt; Amitesh Roy; Kathryn Cornthwaite; Christos S Karapetis; Susanne K Pedersen
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-10       Impact factor: 4.553

2.  Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways.

Authors:  A R Dallosso; B Øster; A Greenhough; K Thorsen; T J Curry; C Owen; A L Hancock; M Szemes; C Paraskeva; M Frank; C L Andersen; K Malik
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

3.  A CTCF-Binding Element and Histone Deacetylation Cooperatively Maintain Chromatin Loops, Linking to Long-Range Gene Regulation in Cancer Genomes.

Authors:  Ran Tang; Yiqun Li; Fang Han; Zhenzhi Li; Xiaoyu Lin; Haoxiu Sun; Xiaoqing Zhang; Qinghua Jiang; Huan Nie; Yu Li
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

4.  Long range epigenetic silencing is a trans-species mechanism that results in cancer specific deregulation by overriding the chromatin domains of normal cells.

Authors:  Marta Forn; Mar Muñoz; Daniele V F Tauriello; Anna Merlos-Suárez; Verónica Rodilla; Anna Bigas; Eduard Batlle; Mireia Jordà; Miguel A Peinado
Journal:  Mol Oncol       Date:  2013-08-30       Impact factor: 6.603

5.  Master regulators of infiltrate recruitment in autoimmune disease identified through network-based molecular deconvolution.

Authors:  James C Chen; Jane E Cerise; Ali Jabbari; Raphael Clynes; Angela M Christiano
Journal:  Cell Syst       Date:  2015-11-25       Impact factor: 10.304

Review 6.  Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction.

Authors:  Farah J Nassar; Zahraa S Msheik; Rihab R Nasr; Sally N Temraz
Journal:  Clin Epigenetics       Date:  2021-05-17       Impact factor: 6.551

7.  DNA methylation profiles of airway epithelial cells and PBMCs from healthy, atopic and asthmatic children.

Authors:  Dorota Stefanowicz; Tillie-Louise Hackett; Farshid S Garmaroudi; Oliver P Günther; Sarah Neumann; Erika N Sutanto; Kak-Ming Ling; Michael S Kobor; Anthony Kicic; Stephen M Stick; Peter D Paré; Darryl A Knight
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

8.  Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation.

Authors:  Paul L Severson; Erik J Tokar; Lukas Vrba; Michael P Waalkes; Bernard W Futscher
Journal:  Epigenetics       Date:  2012-09-13       Impact factor: 4.528

9.  Identification of differentially methylated regions using streptavidin bisulfite ligand methylation enrichment (SuBLiME), a new method to enrich for methylated DNA prior to deep bisulfite genomic sequencing.

Authors:  Jason P Ross; Jan M Shaw; Peter L Molloy
Journal:  Epigenetics       Date:  2012-12-20       Impact factor: 4.528

10.  Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia.

Authors:  Susanne K Pedersen; Erin L Symonds; Rohan T Baker; David H Murray; Aidan McEvoy; Sascha C Van Doorn; Marco W Mundt; Stephen R Cole; Geetha Gopalsamy; Dileep Mangira; Lawrence C LaPointe; Evelien Dekker; Graeme P Young
Journal:  BMC Cancer       Date:  2015-10-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.